Sign in
INO Stock Price, Chart, Stats & News
Inovio Pharmaceuticals, Inc.
Save
61.36M
Market cap
–
Current P/E
16.58x
Forward P/E
INO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -0.11% |
ROE | -353.36% |
D/E | 388.77x |
Interest coverage ratio | – |
INO valuation
P/E | – |
P/S | – |
P/B | 31.33x |
P/CF | -0.04x |
P/FCF | -0.00x |
P/OCF | -0.04x |
PEG | -0.32x |
EV multiple | 89.51x |
About
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen.
Similar securities
Based on sector and market capitalization
Report issue